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1. The historical background of immunology
When we are reading or investigating the topics of cellular and molecular 
immunology including cytokines, our unconscious mind suddenly goes back to 
the Iranian “Immunologist King,” Mithridates VI Eupator of Pontus. Pontus is a 
Greek term referring to the Sea; but conceptually – in accordance with geographic 
evidences of that time period – it refers to the Black Sea. Indeed, he is known as the 
first immunologist in the ancient world [1–4].
Mithridates VI Eupator of Pontus (reigned 120–163 BC), the son of Mithridates 
V Euergetes, was proud over his Iranian heritage and ruled the Pontus region 
(Asia Minor, The Great Persia Empire Region; Present-day Turkey) throughout 
the Hellenistic and Mithridatic Kingdoms. Despite accepting Hellenism, he always 
considered himself as an Iranian king from royal Achaemenid lineages. Indeed, 
his Iranian origin went back as far as Darius I and Cyrus the Great (The King of 
Kings). His name Mithridates depicts the God of Light (Mithradatha: sent (given) 
by Mithra, the ancient Iranian God of Sun) [1, 2, 5–7].
Mithridates VI Eupator of Pontus is the founder of the Mithridatism theory which 
refers to the phenomenon of acquired immunity against poisons, by using determined 
doses of the poison to expose the individual to the agent little by little [8]. Hence, he 
used cocktails of antidotes against currently known poisons every day. The potion of 
Mithridates VI Eupator of Pontus was a mixture of 54 currently known poisons which 
was termed “Antidotum Mithridaticum.” His popular poisonous potion was con-
sumed by people from all walks of life for about two millennia [6, 9, 10]. This process 
is very similar to the act of vaccination and may be considered as a preliminary form 
of preventive medicine [11].
Mithridates VI Eupator of Pontus was a genius because he was not only an 
exceptional expert in immunization and toxicology, but he could also talk in 22–25 
different languages. Moreover, he was interested in medicine and pharmacology; 
therefore, Mithridates VI Eupator of Pontus has written several treatises regard-
ing the characteristics of “materia medica” together with the related cases. These 
invaluable Mithridatic treatises were translated into Latin between 95 and 25 BC by 
Lenaeus, which were recognized as unique and effective prescriptions in Rome [12].
He was a researcher in the fields of immunology, toxicology, pharmacology, and 
medicine [4, 11, 12]. Due to this fact, the Iranian king, Mithridates VI Eupator of 
Pontus is a shining star in the treasure of science and history of Iran.
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2. The immune system and cytokines
After about 2000 years, the basis of our knowledge and understanding of the 
immune system and immunity is very similar; however, what has changed is our 
ability to have an invaluable interpretation from our scientific observations.
The progression of cellular and molecular biology, together with bioinformat-
ics, computational biology, and medicinal chemistry has given us an opportunity 
to have an effective understanding of the role of versatile molecules, proteins, and 
glycoproteins in different fields of immunology.
As we know today, the immune system is a complex network, containing wide 
range of cells and molecules which works rigorously and around the clock. The 
main sections of the immune system are divided into the innate and adaptive 
immune structures, while at the same time they create a unite and interdependent 
complex.
The unity of innate and adaptive immune system is supported by the diversity 
of common molecules, cells, mechanisms, processes, and pathways. However, the 
innate immune system is activated first and by the continuous of the presence of 
the unknown antigen(s), the adaptive immune system will be activated, usually a 
few days later. Besides, B- and T- lymphocytes have pivotal roles in maintaining the 
adaptive immune system and a long-lasting immune response [13].
The immune system – whether innate or adaptive– employs versatile mecha-
nisms to protect the host’s body from various “invaders,” including pathogens or 
any other agents which may cause any type of disease. In this regard, the proteins of 
cytokines and chemokines are produced by different activated immune and non-
immune cells and cell receptors, which they convoke a mass of molecules and cells 
into the center of infection [13].
Therefore, cytokines are noteworthy molecules, with a diversity of activities, 
functions, structures, and potential abilities. Due to this characteristic of cytokines 
makes them like “diamonds” and “pearls” of the immune system. Cytokines are 
invaluable treasure of the immune system with a high plasticity in functions and 
structures.
They join not only the all parts of the immune system together and unite them 
as a whole, but also the cytokines contribute in non-immune cells and molecules 
to orchestrate different cells, tissues, organs, and systems. That is why we may call 
cytokines as diamonds and pearls of the biological systems.
3. Immune system and cytokines
Cytokines were first described as soluble pyrexins by Menkin in 1944 [14]. The 
term “cytokine” was proposed (coined) by Cohen et al. through their commentary, 
published in 1974 [15, 16].
From that point onward, our knowledge regarding cytokines increased signifi-
cantly. Therefore, in 1978, more than 100 different types activities were described, 
in association with cytokines [14].
Cytokines comprise a diverse group of proteins and glycoproteins, with 
molecular weights ranging between 5 and 20 kDa [17, 18]. These amazing molecules 
contribute to different biological and physiological mechanisms, such as blood 
pressure, inflammation, and cellular metabolism [18, 19]. Cytokines act locally, and 
therefore, they affect their peripheral cells in a paracrine style and the producing 
cells in an autocrine manner. Those cytokines, which disseminate via blood stream 
across the body act in an endocrine fashion, similarly to hormones. Due to this fact, 
there are no clear differences between hormones and cytokines, and the employed 
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molecules by different biologic systems involving endocrine functions, hemato-
poiesis, immunity, and the nerves have similar characteristics in their functions 
and structures [13, 14, 16]. In another words, cytokines orchestrate hematopoietic, 
immune, and non-immune cells of the host in their development, differentiation, 
function, growth, and regulation, throughout the employment of paracrine and 
autocrine signaling pathways [13, 16, 19, 20]. Indeed, cytokines regulate, modulate, 
and orchestrate biological systems, for example, innate and adaptive immune sys-
tem networks by induction of their own secretion [13]. In this regard, the Human 
Genome Project (HGP) has had an important role to recognize the different types 
of cytokines and their association with health and diseases [19]. The homeostasis 
across the systems of the human body is provided by an influent balance between 
anti-inflammatory and pro-inflammatory cytokines. Hence, the expression of 
genes producing cytokines is entirely modulated by long non-coding RNAs, both in 
transcriptional and post-transcriptional phases [18].
Cytokines are multifunctional proteins with a versatile of receptors, which are 
distributed in different systems of the body. Therefore, they can be categorized in 
accordance with variety plethora of criteria. However, it is recommended that the 
cytokines’ classification would be on the basis of their receptors [16, 21]. Cytokines 
activate the related signaling pathway by their specific intracellular signaling 
cascades [13]. The major superfamilies of cytokine receptors are consisting of 
Transforming Growth Factor-β (TGF-β), Tumor Necrosis Factor (TNF) receptor, 
Serine Kinases family, Receptor Tyrosine kinases, Interleukin-1 (IL-1) and the 
related Toll-like Receptors (TLR), IL-17 receptors Type II (interferon), and Type 
I (hematopoietin) [16]. The chemokine receptor includes the G protein-coupled 
receptor family [19].
The type I receptor family, which is known as the hematopoietin receptor 
family, receives different types of cytokines including IL-2, IL-3, IL-4, IL-5 IL-6, 
IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, IL-21, IL-23, IL-27, IL-31, IL-35, growth 
hormone (GH), prolactin (PRL), erythropoietin (EPO), thrombopoietin (TPO), 
leptin, granulocyte colony stimulating factor (G-CSF), ciliary neurotrophic factor 
(CNTF), leukemia inhibitory factor (LIF), oncostatin M (OM), cardiotropin-1 
(CT-1), granulocyte macrophage (MΦ) colony stimulating factor (GM-CSF), and 
thymic stromal lymphopoietin (TSLP) [16]. Type I receptor family is structurally 
composed of homo- or heterodimers [19].
Figure 1. 
The structure of IL-4 in details 1HIK PDB file [22, 23].
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The type I cytokines are similar in their protein structure, with four anti-parallel 
α-helices with a configuration of up-up and down-down arrangement. The helices 
are connected with two long loops and one short loop [16]. This structure is shown 
in IL-4 (Figure 1) [22].
Type II receptor family or interferons (IFNs) with their homo- and heterodi-
meric structures have high affinity for their ligands, including IFN-α/β, IFN-γ, 
IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, IL-29, and IL-30 [16, 19].
The single pass membrane receptors of IL-1/TLRs bind to cytokines of IL-1α/β, 
IL-18, IL-33, IL-36, IL-37, and IL-38 [16, 19].
The IL-17 and TGF-β receptor serine kinase families bind to IL-7 and TGF-β 
cytokines, respectively [16].
The receptor tyrosine kinases, which phosphorylate tyrosine residues bind to 
a wide range of cytokines including IL-3, IL-16, IL-32, stem cell factor (SCF) and 
CSF-1, and FMS-like tyrosine kinase 3 (FLT-3) ligand [16, 19].
4. Cytokines and signaling pathways
Cytokines originate from the flat sac organelles of the Golgi-apparatus. These 
biological diamonds and pearls may have four different predestinations, including 
soluble cytokines released from endoplasmic reticulum, cytokines linked to the 
plasma membranes, intracellular cytosolic cytokines, and nuclear cytokines, and 
the latter group controls the process of transcription [19].
Regulation of cytokines may occur in different pathways, such as transcriptional 
and post-transcriptional regulations. At transcriptional level, the presence of sev-
eral transcription factors determines the level of cytokine expression and produc-
tion. In contrast to transcriptional regulation, the post-transcriptional regulation 
determines the duration of cytokines’ expression. Moreover, the type of cytokines’ 
glycosylation determines their functions and activity [18, 19, 24, 25].
As mentioned previously, there are several types of receptors which bind 
secreted cytokines. Due to this fact, the related receptors based on their signaling 
pathway are divided into four receptor groups. The first receptor group is in associa-
tion with nuclear factor (NF)-κB and mitogen-activated protein kinases (MAPK); 
the second group involves receptors which employs Smad-family transcription fac-
tors; the third category of receptors activates the Ras extracellular signal-regulated 
kinase (ERK) pathway; and the fourth group which involves the majority of recep-
tors uses the Janus kinase and signal transducers and activators of transcription 
(JAK-STAT) pathway [26].
The JAK family is composed of four members including JAK1, JAK2, JAK3, 
and TYK2, which are known as non-receptor multi-domain tyrosine kinases and 
recognized within the cell’s cytoplasm [27, 28]. On the other hand, activation of JAK 
family members may lead to phosphorylation of tyrosine residues which belong to 
intracellular domains of the cytokine receptor. The STAT links to phosphorylated 
tyrosine residues of cytokine receptors. By STAT phosphorylation, the STAT allows 
for the ability of dimerization, transmission into the nucleus. Furthermore, the 
STAT will be able to manage the process of gene regulation [27–29].
These interactions reveal the importance of different cytokines, cytokines 
receptors, and cytokine signaling pathways; in which, the occurrence of any muta-
tion may lead to different immune and non-immune disorders and diseases. Hence, 
in accordance with complicated interactions and communications in cytokines 
network, we can understand that recognition of cytokines, cytokine receptors, and 
their signaling pathways in details may lead us to a great opportunity for definite 
treatment of the immune and non-immune disorders.
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We can conclude that, although Mithridates VI Eupator of Pontus as an Iranian 
Immunologist/Toxicologist/Pharmacologist King never had an idea about these 
biological “diamonds” and “pearls” regarded as cytokines, their receptors, and 
signaling pathway, he was aware of the harmonic communications between organs 
and systems within the human body.
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